Omada Health Presents AI-Powered Meal Feedback Research and 12-Month GLP-1 Care Track Outcomes at ObesityWeek 2026
Omada: 3 Key Takeaways for Long-Term Investors
Omada Health, Inc. (OMDA) Q3 2026 Earnings Call Transcript
What Changes For Omada Health (OMDA) As It Names A New CEO?
Omada Health (OMDA) Stock May Be Fully Priced Following Raised Guidance
Omada Health (OMDA) Dropped, So What Is Behind The Attention Now?
Omada Health (OMDA) Q3 2026 Earnings Call Transcript
Omada Health Q3 2026 Earnings Call Summary
What Omada Health (OMDA) Said on Its Q3 Earnings Call
Barclays Maintains Overweight on Omada Health, Lowers Price Target to $22
Wells Fargo Maintains Equal-Weight on Omada Health, Lowers Price Target to $19
Omada Health Inc (OMDA) (Q3 2026) Earnings Call Highlights: Record Revenue, Membership Growth, ...
Compared to Estimates, Omada Health, Inc. (OMDA) Q3 Earnings: A Look at Key Metrics
Omada Health Reports Third Quarter 2026 Results
Omada Health Q3 2026 Earnings Call Transcript
Omada Health Raises FY2026 Sales Guidance from $334.000M-$340.000M to $344.000M-$346.000M vs $338.537M Est
Omada Health Q3 EPS $0.10 Beats $0.02 Estimate, Sales $91.000M Beat $85.676M Estimate
Barclays Maintains Overweight on Omada Health, Lowers Price Target to $24
Omada Health to Present Peer-Reviewed Research on Improving Weight Loss and Body Composition During GLP-1 Treatment at World Obesity and Weight Management Congress
Omada Health To Present Published Research Showing That Members Of Its GLP-1 Care Track Lost More Weight And Experienced Greater Improvements In Body Composition Than GLP-1 Users Receiving Usual Care
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.